Stock AMDA ALMEDA VENTURES LIMITED PARTNERSHIP
Add to a list
To use this feature you must be a member
Log inSign up

Financials Almeda Ventures Limited Partnership

Equities

AMDA

IL0011689622

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:54:26 06/06/2024 pm IST 		5-day change 1st Jan Change
185 ILa 0.00% Intraday chart for Almeda Ventures Limited Partnership 0.00% -9.76%
2023 BioProtect Ltd. announced that it has received $28 million in funding from MVM Partners LLP, Triventures, KB Investment Co., Ltd., Peregrine Ventures, Almeda Ventures Limited Partnership, Vincos Limited CI
2023 BioProtect Ltd. announced that it has received funding from Almeda Ventures Limited Partnership CI

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 15.22 18.01 4.65
Enterprise Value (EV) 1 2.66 8.713 -1.135
P/E ratio - 487 x -7.29 x
Yield - - -
Capitalization / Revenue - 1,12,80,119 x 51,26,484 x
EV / Revenue - 54,56,074 x -12,51,686 x
EV / EBITDA - 24,89,52,880 x 17,82,228 x
EV / FCF - 4,51,76,154 x 29,98,427 x
FCF Yield - 0% 0%
Price to Book - 0.66 x 0.17 x
Nbr of stocks (in thousands) 6,909 12,322 12,322
Reference price 2 2.203 1.462 0.3774
Announcement Date 17/02/21 20/03/22 28/03/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales - 1.597 0.907
EBITDA - 0.035 -0.637
EBIT 1 -0.6257 0.034 -0.639
Operating Margin - 2.13% -70.45%
Earnings before Tax (EBT) 1 -0.4714 0.052 -0.641
Net income 1 -0.4714 0.052 -0.64
Net margin - 3.26% -70.56%
EPS - 0.003000 -0.0517
Free Cash Flow - 0.1929 -0.3786
FCF margin - 12.08% -41.74%
FCF Conversion (EBITDA) - 551.07% -
FCF Conversion (Net income) - 370.91% -
Dividend per Share - - -
Announcement Date 17/02/21 20/03/22 28/03/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 - - -
Net Cash position 1 12.6 9.3 5.79
Leverage (Debt/EBITDA) - - -
Free Cash Flow - 0.19 -0.38
ROE (net income / shareholders' equity) - 0.22% -2.36%
ROA (Net income/ Total Assets) - 0.09% -1.45%
Assets 1 - 57.59 44.22
Book Value Per Share - 2.220 2.170
Cash Flow per Share - 0.7700 0.4800
Capex - 0 -
Capex / Sales - 0.13% -
Announcement Date 17/02/21 20/03/22 28/03/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ALMEDA VENTURES LIMITED PARTNERSHIP Stock Almeda Ventures Limited Partnership
-9.76% 6.08M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+9.48% 222B
DANAHER CORPORATION Stock Danaher Corporation
+13.72% 195B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+23.79% 148B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.39% 113B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+4.75% 66.45B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.59% 53.11B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.16% 50.03B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-4.35% 38.8B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-1.27% 34.85B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AMDA Stock
  4. Financials Almeda Ventures Limited Partnership